Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 34Head and Neck Neoplasms 13Squamous Cell Carcinoma of Head and Neck 12Rectal Neoplasms 12Melanoma 12Colorectal Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Lung Neoplasms 11Colonic Neoplasms 10Pancreatic Neoplasms 8Carcinoma, Renal Cell 8Prostatic Neoplasms 7Lymphoma, Follicular 7Breast Neoplasms, Male 7Unspecified Adult Solid Tumor, Protocol Specific 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, B-Cell, Marginal Zone 6Carcinoma, Ovarian Epithelial 6Ovarian Neoplasms 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Gliosarcoma 5Glioblastoma 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Oligodendroglioma 4Liver Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Kidney Neoplasms 4

Interventions

Paclitaxel 95Carboplatin 76pembrolizumab 72Cisplatin 28Bevacizumab 27Letrozole 22Radiotherapy 21Doxorubicin 21Megestrol Acetate 20lenvatinib 19olaparib 18Taxes 17Docetaxel 17Nivolumab 16Specimen Handling 15Metformin 15dostarlimab 14Magnetic Resonance Spectroscopy 14Gemcitabine 13durvalumab 12Medroxyprogesterone Acetate 12Trastuzumab 11Indocyanine Green 11Fulvestrant 11Biopsy 11temsirolimus 10abemaciclib 10atezolizumab 9Radiation 9Early Intervention, Educational 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Endometrial Neoplasms × Immunohistochemistry × Clear all
NCT00770185 2023-08-04

Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer

Canadian Cancer Trials Group

Phase 2 Completed
35 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡